Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Bionexus Gene Lab Corporation was the first Nasdaq-listed company Ethereum (ETH) to Bitcoin (BTC) chosen as strategic ...

BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

Ethereum ETF flows have shown volatility, signaling uncertainty for ETH's short-term recovery. Despite institutional interest ...

Additionally, BioNexus sees Ethereum’s deep integration in the global financial ecosystem as a key factor. The Ethereum ...

Ethereum’s bullish momentum continues, driven by the Pectra upgrade and BioNexus announcement, pushing ETH towards a ...

Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other ...

Ethereum [ETH] ETF flows turned positive after 10 days of an outflow trend, signaling a likely renewed demand for the altcoin. On the 4th of March, the products logged $14.58M inflows, and marched ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as ...